Posters - NCDEU: An Annual Meeting Sponsored by ASCP

Posters
37. Clinical Profiles of Response and Remission in STAR*D
Felipe Jain, UCLA Semel Institute for Neuroscience and Resnick
Neuropsychiatric Hospital
Aimee Hunter, John Brooks, Andrew Leuchter
38. The Clinical Relevance of Results Achieved with Vilazodone in the
Treatment of Major Depressive Disorder
Arif Khan, Duke University School of Medicine, Northwest Clinical
Research Center
John Edwards, Wenjie Song, Adam Ruth
39. Adjunctive Aripiprazole Doubles the Rate of Early and Sustained
Response in MDD Patients with an Inadequate Response to
Antidepressant Monotherapy
Kimberly Laubmeier, Bristol-Myers Squibb
Daniel Casey, James Eudicone, Ronald Marcus, Robert Berman, Ross
Baker, Jack Sheehan
40. Development of a New Depression Rating Scale, The Rosenberg
Mood Scale
Leon Rosenberg, Center for Emotional Fitness
Howard Hassman
41. Repeated Administrations of Ketamine in Treatment-Resistant
Major Depression: Rapid Antidepressant Effects and Durability of
Response
James Murrough, Mount Sinai School of Medicine
Andrew Perez, Sarah Pillemer, Jessica Stern, Kyle Lapidus, Laili
Soleimani, Diogo Alves, Dennis Charney, Dan Iosifescu
42. Selegiline Transdermal System (STS) for Major Depressive
Disorder (MDD) with Atypical Features: A Post-hoc Analysis of
Data from an Open-label, 10-week Trial
Terry Painter, Dey Pharma, LP
Saeheon Jang, Sungwon Jung, Chiun Pae, Kimberly Portland, Rob
Mariani, Paul Mastoridis, Ashwin Patkar
43. L-methylfolate Produces a Robust Effect on Core Symptoms
using Maier Subscale Scores in a Randomized Clinical Trial of
Patients with Major Depression
George Papakostas, Massachusetts General Hospital
Stephen Stahl
= New Investigator Awardee
87